1,731 results on '"Brenner, Malcolm K."'
Search Results
2. Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
3. Editorial Expression of Concern: E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells
4. IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer
5. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies
6. Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis
7. Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity
8. LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study
9. Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
10. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
11. Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation
12. Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
13. Targeting glycans for CAR therapy: The advent of sweet CARs
14. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs
15. Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy
16. Mesenchymal Stromal Cells Protect Combined Oncolytic and Helper Dependent Adenoviruses from Humoral Immunity
17. Improving the safety of iPSC-derived T cell therapy
18. Contributors
19. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant
20. Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
21. Taking T-Cell Oncotherapy Off-the-Shelf
22. LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001) results from arm 1 of a non-randomised, single-centre, phase 1/2 study
23. Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
24. Off-the-Shelf CD19-Specific CAR-NKT Cells in Patients with Relapsed or Refractory B-Cell Malignancies
25. Engineered off-the-shelf therapeutic T cells resist host immune rejection
26. A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy
27. Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
28. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients
29. CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
30. Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed/Refractory Mature T-cell Lymphomas
31. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas
32. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation
33. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
34. Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 to 2016
35. Primitive Adult Hematopoietic Stem Cells Can Function as Osteoblast Precursors
36. c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals
37. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
38. Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
39. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
40. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
41. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
42. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
43. Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape
44. Data from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
45. Supplemental Table 1 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
46. Supplementary Fig. S1 from Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
47. Supplemental Figure 4 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
48. Supplemental Figure 3 from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
49. Supplemental Figure Legends from Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
50. Data from Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.